Occuity enters Boehringer Ingelheim start-ups acceleration program Synapse Acceleration®
Occuity enters Boehringer Ingelheim start-ups program Synapse Acceleration®, looking at non-invasive glucose monitoring in veterinary
Occuity enters Boehringer Ingelheim start-ups acceleration program Synapse Acceleration®
Why is Type 2 diabetes on the rise amongst UK under 40s?
Diabetes & Myopia In the News
Understanding the aqueous humor
Angels invest in healthcare tech startup Occuity